# FDA Inspection 1298224 - Corixa Corporation - March 12, 2026

Source: https://www.keypedia.com/records/fda_inspections/corixa-corporation/b3553978-985f-4f9f-adf0-0cb69251dad9
Source feed: FDA_Inspections

> FDA Inspection 1298224 for Corixa Corporation on March 12, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298224
- Company Name: Corixa Corporation
- Inspection Date: 2026-03-12
- Project Area: Vaccine, Allergenic, and Live Biotherapeutic Products
- Product Type: Biologics
- Office Name: Philadelphia District Office

## Related Documents

- [FDA Inspection 1229084 - 2024-02-09](https://www.keypedia.com/records/fda_inspections/corixa-corporation/91f1c34e-f8ed-43de-852d-ffc1870c7427)
- [FDA Inspection 1091132 - 2019-04-15](https://www.keypedia.com/records/fda_inspections/corixa-corporation/2e7ea474-d1f6-4666-8216-cfa8bbdd1120)
- [FDA Inspection 1016267 - 2017-05-16](https://www.keypedia.com/records/fda_inspections/corixa-corporation/c2db1e9f-95ba-4300-8f45-160737c1037a)
- [FDA Inspection 938930 - 2015-05-13](https://www.keypedia.com/records/fda_inspections/corixa-corporation/0ee28b79-92f5-424e-8bf4-1d63f67facc4)

Company: https://www.keypedia.com/companies/corixa-corporation/540054c0-cf35-42d2-9056-a9ae897ff412

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8